loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

Technical details about camostat mesilate, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
Also known as: Camostat mesilate, 59721-29-8, Camostat (mesylate), Camostat methanesulfonate, Foipan, Camostate
Molecular Formula
C21H26N4O8S
Molecular Weight
494.5  g/mol
InChI Key
FSEKIHNIDBATFG-UHFFFAOYSA-N
FDA UNII
451M50A1EQ

Camostat Mesylate is the mesylate salt form of camostat, an orally bioavailable, synthetic serine protease inhibitor, with anti-inflammatory, antifibrotic, and potential antiviral activities. Upon oral administration, camostat and its metabolite 4-(4-guanidinobenzoyloxyl)phenyl acetic acid (FOY 251) inhibit the activities of a variety of proteases, including trypsin, kallikrein, thrombin and plasmin, and C1r- and C1 esterases. Although the mechanism of action of camostat is not fully understood, trypsinogen activation in the pancreas is known to be a trigger reaction in the development of pancreatitis. Camostat blocks the activation of trypsinogen to trypsin and the inflammatory cascade that follows. Camostat may also suppress the expression of the cytokines interleukin-1beta (IL-1b), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a) and transforming growth factor-beta (TGF-beta), along with alpha-smooth muscle actin (alpha-SMA). This reduces inflammation and fibrosis of the pancreas. In addition, camostat may inhibit the activity of transmembrane protease, serine 2 (TMPRSS2), a host cell serine protease that mediates viral cell entry for influenza virus and coronavirus, thereby inhibiting viral infection and replication.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate;methanesulfonic acid
2.1.2 InChI
InChI=1S/C20H22N4O5.CH4O3S/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22;1-5(2,3)4/h3-10H,11-12H2,1-2H3,(H4,21,22,23);1H3,(H,2,3,4)
2.1.3 InChI Key
FSEKIHNIDBATFG-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
451M50A1EQ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Camostat

2. Camostat Mesilate

3. Camostate

4. Camostate-mesilate

5. Foipan

6. Foy 305

7. Foy S 980

8. Foy-305

9. Foypan

10. N,n-dimethylcarbamoylmethyl-4-(4-guanidinobenzoyloxy)phenylacetate Methanesulfonate

11. P-guanidinobenzoic Acid, Ester With (p-hydroxyphenyl)acetic Acid, Ester With N,n-dimethylglycolamide

2.3.2 Depositor-Supplied Synonyms

1. Camostat Mesilate

2. 59721-29-8

3. Camostat (mesylate)

4. Camostat Methanesulfonate

5. Foipan

6. Camostate

7. Mfcd00941410

8. Foy305

9. Camostat Mesilate [jan]

10. Camostat Mesilate;foy305;foy-s980

11. Dsstox_cid_238

12. 4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate Methanesulfonate

13. Dsstox_rid_75452

14. Dsstox_gsid_20238

15. Chembl85164

16. 2-(dimethylamino)-2-oxoethyl 4-(4-guanidinobenzoyloxy)phenylacetate Methanesulphonate

17. Methanesulfonic Acid 4-{2-[(dimethylcarbamoyl)methoxy]-2-oxoethyl}phenyl 4-carbamimidamidobenzoate

18. 451m50a1eq

19. Cas-59721-29-8

20. Ncgc00167526-01

21. Foy-305

22. Foipan (tn)

23. Camostat Mesylate- Bio-x

24. Camostat Mesilate (jp17)

25. Mls006010697

26. Schembl871583

27. Foy-s980

28. Camostat Mesilate (foy-305)

29. Dtxsid0020238

30. Chebi:31347

31. Amy8832

32. Camostat Mesilate [mart.]

33. Hms3651d04

34. Camostat Mesilate [who-dd]

35. Bcp06708

36. Ex-a4154

37. Tox21_112523

38. Camostat Mesylate, >=98% (hplc)

39. S2874

40. Camostat Methanesulfonate [mi]

41. Akos015966692

42. Akos026750463

43. Tox21_112523_1

44. Ac-8540

45. Ccg-269652

46. Hs-0060

47. Ncgc00167526-02

48. 4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-((diaminomethylene)amino)benzoate Methanesulfonate

49. 4-[[4-[(aminoiminomethyl)amino]benzoyl]oxy]benzeneacetic Acid 2-(dimethylamino)-2-oxoethyl Ester Methanesulfonate

50. Bc164270

51. Hy-13512

52. Smr002530343

53. Sy060177

54. Db-072684

55. B2082

56. Ft-0648873

57. Sw219517-1

58. D01766

59. F20649

60. 721c298

61. A832436

62. Q-200778

63. Q23731028

64. 4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl4-guanidinobenzoatemethanesulfonate

65. 4-(2-{[2-(dimethylamino)-2-oxoethyl]oxy}-2-oxoethyl)phenyl 4-{[amino(imino)methyl]amino}benzoate Methanesulfonate

66. 4-{2-[(dimethylcarbamoyl)methoxy]-2-oxoethyl}phenyl 4-[(diaminomethylidene)amino]benzoate; Methanesulfonic Acid

2.4 Create Date
2005-11-20
3 Chemical and Physical Properties
Molecular Weight 494.5 g/mol
Molecular Formula C21H26N4O8S
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count9
Exact Mass494.14713497 g/mol
Monoisotopic Mass494.14713497 g/mol
Topological Polar Surface Area200 Ų
Heavy Atom Count34
Formal Charge0
Complexity695
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Trypsin Inhibitors

Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. (See all compounds classified as Trypsin Inhibitors.)


Protease Inhibitors

Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)


Post Enquiry
POST ENQUIRY